Teva Settles Foreign Corruption Probe for $519 Million - WSJ
La farmacéutica Teva ofrece US$40.000 millones por Mylan - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
PHARMACOSERÍAS Marketing Farmacéutico/Pharmaceutical Marketing: TEVA: Camino dificil para nuevo CEO
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ
Una aplicación permite leer el Wall Street Journal sin pagar – Albert Cuesta
Drug Distributors and Teva Reach Settlement in Ohio Opioid Litigation - WSJ
The Wall Street Journal' preveu "l'acceleració" de la ruptura entre Catalunya i Espanya
Teva, denying 'any liability,' set aside $646M for opioid settlements. Here's why | Fierce Pharma
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ
With Allergan deal sealed, Teva turns its attention to branded M&A | Fierce Pharma
FDA's Call on Migraine Drug Could Be Trouble for Teva | Barron's
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Part of Consortium Looking to Participate in Purdue Pharma's Bankruptcy, Report Says | Ctech
